In addition, we identified natural small molecule drugs that can target vasculogenic mimicry-related core target proteins by molecular docking, and finally, we verified that CDH5 promotes the proliferation and invasion of renal clear cell carcinoma by in vitro experiments. Here, CDH5 is linked to clear cell renal carcinoma.